CAS 180465-02-5 | Bicyclo[1.1.1]pentane-1-acetic acid, α-amino-3-carboxy-, (αS)- | CAS Number 180465-02-5

200,000+ products from a single source!

sales@angenechem.com

Product Categories

Home > Amines > 180465-02-5

180465-02-5 | Bicyclo[1.1.1]pentane-1-acetic acid, α-amino-3-carboxy-, (αS)-

CAS No: 180465-02-5 Catalog No: AG002206 MDL No:MFCD00949088

Product Description

Catalog Number:

AG002206

Chemical Name:

Bicyclo[1.1.1]pentane-1-acetic acid, α-amino-3-carboxy-, (αS)-

CAS Number:

180465-02-5

Molecular Formula:

C8H11NO4

Molecular Weight:

185.1772

MDL Number:

MFCD00949088

IUPAC Name:

3-[(S)-amino(carboxy)methyl]bicyclo[1.1.1]pentane-1-carboxylic acid

InChI:

InChI=1S/C8H11NO4/c9-4(5(10)11)7-1-8(2-7,3-7)6(12)13/h4H,1-3,9H2,(H,10,11)(H,12,13)/t4-,7?,8?/m1/s1

InChI Key:

KNSHLWJBSDBBRH-XOJFDHPMSA-N

SMILES:

OC(=O)[C@H](C12CC(C1)(C2)C(=O)O)N

Properties

Complexity:

279

Compound Is Canonicalized:

Yes

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Exact Mass:

185.069g/mol

Formal Charge:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Isotope Atom Count:

Molecular Weight:

185.179g/mol

Monoisotopic Mass:

185.069g/mol

Rotatable Bond Count:

Topological Polar Surface Area:

101A^2

Undefined Atom Stereocenter Count:

Undefined Bond Stereocenter Count:

XLogP3:

-3.3

Literature

Title	Journal
Propofol: neuroprotection in an in vitro model of traumatic brain injury.	Critical care (London, England) 20090101
Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury.	Critical care (London, England) 20090101
Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo.	Pharmacology, biochemistry, and behavior 20020901
Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges.	British journal of pharmacology 20010201
Biochemical and electrophysiological studies on (S)-(+)-2-(3'-carboxybicyclo(1.1.1)pentyl)-glycine (CBPG), a novel mGlu5 receptor agonist endowed with mGlu1 receptor antagonist activity.	Neuropharmacology 19990701